Duchenne muscular dystrophy: CRISPR/Cas9 treatment

被引：41
|
作者：
Mendell, Jerry R. [1 ,2 ,3 ]
Rodino-Klapac, Louise R. [1 ,2 ,3 ]
机构：
[1] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA
[2] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA
[3] Ohio State Univ, Columbus, OH 43205 USA
来源：
CELL RESEARCH | 2016年 / 26卷 / 05期
关键词：
MOUSE MODEL; MUSCLE;
D O I：
10.1038/cr.2016.28
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A novel approach to gene correction by genome editing shows great promise as a treatment for Duchenne muscular dystrophy (DMD). CRISPR/Cas9 delivered by adeno-associated virus to a mouse model for DMD demonstrated improvement in function and histology.
引用
收藏
页码：513 / 514
页数：2
相关论文
共 50 条
  • [41] CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne muscular dystrophy
    Guiraud, S.
    Dastidar, S.
    Mazed, F.
    Amor, F.
    Ralu, M.
    de Cian, A.
    Richard, I.
    Ronzitti, G.
    Tedesco, F. S.
    Amendola, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A34 - A34
  • [42] CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy
    Wilton-Clark, Harry
    Yokota, Toshifumi
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 500 - 501
  • [43] Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies
    Fatehi, Sina
    Marks, Ryan M.
    Rok, Matthew J.
    Perillat, Lucie
    Ivakine, Evgueni A.
    Cohn, Ronald D.
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 388 - 403
  • [44] Age-Dependent Echocardiographic and Pathologic Findings in a Rat Model with Duchenne Muscular Dystrophy Generated by CRISPR/Cas9 Genome Editing
    Sugihara, Hidetoshi
    Kimura, Koichi
    Yamanouchi, Keitaro
    Teramoto, Naomi
    Okano, Tomoko
    Daimon, Masao
    Morita, Hiroyuki
    Takenaka, Katsu
    Shiga, Takanori
    Tanihata, Jun
    Aoki, Yoshitsugu
    Inoue-Nagamura, Tokiko
    Yotsuyanagi, Hiroshi
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2020, 61 (06) : 1279 - 1284
  • [45] Correction of a common Duchenne muscular dystrophy mutation by CRISPR/Cas9 gene editing using homology-independent targeted integration
    Nicolau, S.
    Sarff, J.
    Vetter, T.
    Stephenson, A.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [46] CRISPR/CAS9 CORRECTS RETINAL DYSTROPHY IN RATS
    Graham, Dustin M.
    LAB ANIMAL, 2016, 45 (03) : 85 - 85
  • [47] CRISPR/Cas9 corrects retinal dystrophy in rats
    Dustin M. Graham
    Lab Animal, 2016, 45 : 85 - 85
  • [48] CRISPR/CAS9 system corrects PABPN1 mutation in oculopharyngeal muscular dystrophy
    Abu-Baker, Aida
    Rochefort, Daniel
    Dion, Patrick
    Rouleau, Guy
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [49] CRISPR/Cas9 and TALEN edit the DMD genetic mutation in golden retriever muscular dystrophy
    Lopez, S. Mata
    Balog, C.
    Vitha, S.
    Bettis, M.
    Barnett, H.
    Kornegay, J.
    Nghiem, P.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S68 - S68
  • [50] CRISPR/Cas9 Flexes Its Muscles: In Vivo Somatic Gene Editing for Muscular Dystrophy
    VandenDriessche, Thierry
    Chuah, Marinee K.
    MOLECULAR THERAPY, 2016, 24 (03) : 414 - 416
12345